QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

Axsome Therapeutics (AXSM) News Today

$68.59
+1.16 (+1.72%)
(As of 12/5/2023 ET)
Compare
Today's Range
$67.16
▼
$69.31
50-Day Range
$57.42
▼
$73.06
52-Week Range
$53.71
▼
$91.29
Volume
386,359 shs
Average Volume
827,326 shs
Market Capitalization
$3.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$105.50
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
marketbeat.com logoAxsome Therapeutics, Inc. (NASDAQ:AXSM) Position Boosted by Bellevue Group AG
marketbeat.com - December 5 at 12:44 PM
barrons.com logoUPCOMING AXSM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Axsome Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
barrons.com - December 3 at 12:41 PM
seekingalpha.com logoAxsome Therapeutics: Positive Q3, We Like The Launch Success Story
seekingalpha.com - November 27 at 10:41 AM
MarketBeat logoComparing BriaCell Therapeutics (OTCMKTS:BCTXF) & Axsome Therapeutics (NASDAQ:AXSM)
americanbankingnews.com - November 25 at 2:28 AM
finance.yahoo.com logoAxsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7
finance.yahoo.com - November 22 at 9:29 AM
finance.yahoo.com logoAxsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
finance.yahoo.com - November 21 at 8:51 AM
markets.businessinsider.com logoBuy Rating on Axsome Therapeutics: Financial Growth and Promising Pipeline despite Minor Setbacks
markets.businessinsider.com - November 8 at 8:30 PM
markets.businessinsider.com logoHold Rating on Axsome Therapeutics: Unchanged Strategies and Revenue Forecasts Amid Concerns on Future Sales and Profitability Trends
markets.businessinsider.com - November 7 at 1:40 PM
finance.yahoo.com logoAxsome (AXSM) Q3 Loss Widens, Revenues Surpass Estimates
finance.yahoo.com - November 7 at 1:40 PM
finance.yahoo.com logoAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 7 at 8:40 AM
finance.yahoo.com logoQ3 2023 Axsome Therapeutics Inc Earnings Call
finance.yahoo.com - November 7 at 8:40 AM
seekingalpha.com logoAxsome Therapeutics: Costs Outpacing Auvelity Growth (Rating Downgrade)
seekingalpha.com - November 7 at 5:00 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Sangamo Biosciences (SGMO), Axsome Therapeutics (AXSM)
markets.businessinsider.com - November 7 at 12:55 AM
finance.yahoo.com logoAxsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - November 6 at 9:48 AM
finance.yahoo.com logoAxsome Therapeutics Inc (AXSM) Reports 244% YoY Growth in 3Q 2023 Product Revenue
finance.yahoo.com - November 6 at 9:48 AM
finance.yahoo.com logoAxsome Therapeutics and the Global Alzheimer’s Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer’s Disease Awareness Month 2023
finance.yahoo.com - November 2 at 8:19 AM
finance.yahoo.com logoAnalysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - October 30 at 2:20 PM
finance.yahoo.com logoAxsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
finance.yahoo.com - October 24 at 10:33 AM
markets.businessinsider.com logoBuy Rating Assigned to Axsome Therapeutics Amid Positive Prescription Trends for Auvelity
markets.businessinsider.com - October 17 at 2:52 AM
seekingalpha.com logoAxsome Update: Buy At Dips And Hold Forever
seekingalpha.com - October 16 at 6:11 AM
markets.businessinsider.com logoAnalysts’ Top Healthcare Picks: Cytokinetics (CYTK), Axsome Therapeutics (AXSM)
markets.businessinsider.com - October 12 at 10:28 AM
finance.yahoo.com logoAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
finance.yahoo.com - October 11 at 8:13 AM
finance.yahoo.com logoAxsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6
finance.yahoo.com - October 10 at 10:29 AM
markets.businessinsider.com logoTruist Financial Keeps Their Buy Rating on Axsome Therapeutics (AXSM)
markets.businessinsider.com - October 9 at 11:23 PM
msn.com logoMizuho says market fears for Harmony's Wakix drug are "overblown"
msn.com - October 4 at 2:27 PM
markets.businessinsider.com logoMaintaining Buy Rating for Axsome Therapeutics: Steady Auvelity Sales and Anticipated Q3 Performance Insights
markets.businessinsider.com - October 3 at 8:45 AM
finance.yahoo.com logoAxsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week
finance.yahoo.com - October 2 at 10:10 AM
businesswire.com logoAXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
businesswire.com - September 28 at 11:00 PM
finance.yahoo.com logoAxsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day
finance.yahoo.com - September 21 at 9:32 AM
marketbeat.com logoMacquarie Group Ltd. Boosts Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
marketbeat.com - September 21 at 4:16 AM
finance.yahoo.com logoAxsome Therapeutics, Inc.'s (NASDAQ:AXSM) Earnings Haven't Escaped The Attention Of Investors
finance.yahoo.com - September 19 at 8:01 AM
marketbeat.com logoInsider Selling: Axsome Therapeutics, Inc. (NASDAQ:AXSM) Director Sells 11,016 Shares of Stock
marketbeat.com - September 15 at 8:28 PM
marketbeat.com logoBVF Inc. IL Buys 376,100 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
marketbeat.com - September 12 at 4:39 AM
realmoney.thestreet.com logoThis Promising Biotech Is Just Right for a Covered-Call Play
realmoney.thestreet.com - September 10 at 5:22 PM
finance.yahoo.com logoAxsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
finance.yahoo.com - September 7 at 9:29 AM
marketbeat.com logoAxsome Therapeutics, Inc. (NASDAQ:AXSM) Stock Holdings Boosted by WMS Partners LLC
marketbeat.com - September 5 at 1:53 PM
finance.yahoo.com logoAxsome Therapeutics to Present at Three Upcoming Investor Conferences
finance.yahoo.com - September 5 at 7:42 AM
marketbeat.com logoBank of New York Mellon Corp Has $7.72 Million Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
marketbeat.com - September 4 at 4:35 AM
marketbeat.com logoAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Acquired by Profund Advisors LLC
marketbeat.com - September 3 at 6:57 AM
marketbeat.com logoPearl River Capital LLC Buys 1,960 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
marketbeat.com - September 1 at 10:36 AM
seekingalpha.com logoAxsome: Beyond The Numbers - Q2 Earnings Sparkle And A Pipeline Full Of Promise
seekingalpha.com - September 1 at 9:29 AM
marketbeat.com logo96,684 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by ExodusPoint Capital Management LP
marketbeat.com - August 27 at 7:32 AM
nasdaq.com logoCantor Fitzgerald Reiterates Axsome Therapeutics (AXSM) Overweight Recommendation
nasdaq.com - August 22 at 2:57 PM
marketbeat.com logoResources Investment Advisors LLC. Buys 1,621 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
marketbeat.com - August 22 at 6:49 AM
marketbeat.com logoAxsome Therapeutics (NASDAQ:AXSM) Now Covered by Analysts at StockNews.com
marketbeat.com - August 17 at 2:56 AM
msn.com logoBofA upgrades Axsome to neutral, cites improved outlook for MDD drug
msn.com - August 16 at 3:51 PM
marketbeat.com logoUS Bancorp DE Reduces Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
marketbeat.com - August 15 at 6:21 AM
msn.com logoMizuho Maintains Axsome Therapeutics (AXSM) Buy Recommendation
msn.com - August 12 at 10:21 AM
marketbeat.com logoAxsome Therapeutics (NASDAQ:AXSM) PT Raised to $100.00 at Mizuho
marketbeat.com - August 11 at 8:00 AM
marketbeat.com logoFY2024 EPS Estimates for Axsome Therapeutics, Inc. (NASDAQ:AXSM) Reduced by Cantor Fitzgerald
marketbeat.com - August 10 at 9:33 AM
Get Axsome Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter.



AXSM Media Mentions By Week

AXSM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AXSM
News Sentiment
▼
0.50

0.49
▲
Average
Medical
News Sentiment

AXSM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AXSM Articles
This Week
▼
2

4
▲
AXSM Articles
Average Week

Get Axsome Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AXSM) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -